Affinage

TRAPPC6B

Trafficking protein particle complex subunit 6B · UniProt Q86SZ2

Length
158 aa
Mass
18.0 kDa
Annotated
2026-06-10
13 papers in source corpus 5 papers cited in narrative 8 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/6 claims corpus-supported (83%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

TRAPPC6B is a core subunit of the multimeric TRAPP (transport protein particle) tethering complexes required for membrane trafficking to and integrity of the Golgi apparatus (PMID:37713627, PMID:28626029). It is preferentially incorporated into the TRAPP II complex through interaction with TRAPPC3, distinguishing it from its paralogue TRAPPC6A, which partitions equally between TRAPP II and TRAPP III (PMID:37713627). Loss-of-function variants destabilize the complex: the p.Q152* truncation weakens binding to TRAPPC3 and lowers cellular levels of TRAPPC6B together with the TRAPP II-specific subunits TRAPPC9 and TRAPPC10, with a compensatory rise in TRAPPC6A (PMID:37713627). The functional consequence is slowed trafficking into the Golgi and Golgi fragmentation, both rescued by wild-type re-expression (PMID:37713627). This trafficking function is evolutionarily conserved, as human TRAPPC6B complements deletion of its yeast orthologue Trs33 (PMID:39273027). Disrupting TRAPPC6B causes a neurodevelopmental disorder featuring microcephaly, neuronal hyperexcitability, and epilepsy, established through patient variants and recapitulated by zebrafish morphants showing reduced head size and lowered seizure threshold and by neuronal Drosophila knockdown causing locomotor and wing-posture defects (PMID:37713627, PMID:28626029).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 2016 Medium

    Established that specific TRAPPC6B sequence variants disrupt normal transcript processing, providing the first molecular handle on how the gene is inactivated in disease.

    Evidence Minigene transfection splicing assay and RT-PCR of patient transcripts

    PMID:27569842

    Open questions at the time
    • Did not assess the consequence for TRAPP complex assembly or trafficking
    • No in vivo phenotype linked to the splicing defect
  2. 2017 Medium

    Connected TRAPPC6B loss-of-function to a defined neurodevelopmental phenotype, demonstrating the gene is required for normal brain development and neuronal excitability.

    Evidence Patient fibroblast splicing assay plus zebrafish morpholino knockdown with microcephaly and seizure-threshold readouts

    PMID:28626029

    Open questions at the time
    • Morpholino knockdown susceptible to off-target effects, no rescue reported
    • Subcellular trafficking mechanism not addressed
    • Assigned to TRAPP I rather than resolving complex specificity
  3. 2020 Low

    Implicated TRAPPC6B in an intracellular toxin trafficking route, hinting at the breadth of cargo whose transport depends on the protein.

    Evidence RNAi knockdown in ACHN renal epithelial cells with Shiga toxin 2a cytotoxicity readout

    PMID:32188865

    Open questions at the time
    • Single RNAi knockdown without rescue or reciprocal validation
    • No mechanistic placement within the trafficking pathway
    • Relevance to neuronal phenotype unestablished
  4. 2024 High

    Resolved which TRAPP subcomplex TRAPPC6B belongs to and showed how a truncating variant destabilizes it, explaining the trafficking defect mechanistically.

    Evidence Co-IP comparing TRAPP II vs III association and against paralogue TRAPPC6A, Western blot quantification, Golgi trafficking/morphology assays with wild-type rescue in patient fibroblasts, plus Drosophila neuronal RNAi behavioral assays

    PMID:37713627

    Open questions at the time
    • No structural model of how TRAPPC6B is incorporated into TRAPP II
    • Mechanism by which TRAPP II loss produces neuronal hyperexcitability not defined
    • Identity of GTPase substrate/effectors at the Golgi not addressed
  5. 2024 Medium

    Demonstrated functional conservation of TRAPPC6B from yeast to human, confirming the core trafficking role is preserved across species.

    Evidence CRISPR/Cas9 humanized yeast complementation of Trs33 deletion with growth readout

    PMID:39273027

    Open questions at the time
    • Complementation does not map the human-specific TRAPP II interactions
    • Does not address neuronal function directly

Open questions

Synthesis pass · forward-looking unresolved questions
  • How TRAPP II-dependent Golgi trafficking failure translates into microcephaly and neuronal hyperexcitability at the cellular level remains unresolved.
  • No identified molecular link between Golgi fragmentation and neuronal excitability
  • No structural basis for TRAPPC6B incorporation into TRAPP II
  • Cargo spectrum requiring TRAPPC6B in neurons undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005198 structural molecule activity 3 GO:0060090 molecular adaptor activity 2
Localization
GO:0005794 Golgi apparatus 1
Pathway
R-HSA-5653656 Vesicle-mediated transport 2 R-HSA-9609507 Protein localization 1
Complex memberships
TRAPP IITRAPP complex

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2024 TRAPPC6B preferentially associates with the TRAPP II complex over TRAPP III, as shown by co-immunoprecipitation experiments where TRAPPC6B co-precipitated significantly more with TRAPP II, while its homologue TRAPPC6A co-precipitated equally with TRAPP II and TRAPP III. Co-immunoprecipitation from patient-derived fibroblasts and cell lines Brain : a journal of neurology Medium 37713627
2024 Loss-of-function mutation in TRAPPC6B (c.454C>T, p.Q152*) reduces the rate of trafficking into the Golgi apparatus and causes Golgi fragmentation in patient-derived fibroblasts, both of which were rescued by wild-type TRAPPC6B re-expression. Trafficking assay and Golgi morphology imaging in patient-derived fibroblasts with rescue experiment Brain : a journal of neurology High 37713627
2024 The TRAPPC6B p.Q152* mutant shows weakened interaction with TRAPP binding partner TRAPPC3, and patient-derived fibroblasts with this variant show reduced levels of TRAPPC6B as well as TRAPP II complex-specific members TRAPPC9 and TRAPPC10, while TRAPPC6A levels are elevated. Co-immunoprecipitation and Western blotting in patient-derived fibroblasts Brain : a journal of neurology Medium 37713627
2024 Neuronal knockdown of TRAPPC6B in Drosophila impairs locomotion and leads to wing posture defects, supporting a role for TRAPPC6B in neuromotor function. Drosophila TRAPPC6B-deficiency model with neuronal-specific RNAi knockdown and behavioral assays Brain : a journal of neurology Medium 37713627
2017 TRAPPC6B encodes a core subunit of TRAPP I complex; a homozygous splice mutation causing exon-skipping and loss of TRAPPC6B function in patients leads to microcephaly and neuronal hyperexcitability, and zebrafish trappc6b morphants replicate the human phenotype with decreased head size and lower seizure threshold. Patient fibroblast splicing assay (minigene and endogenous transcript), zebrafish morpholino knockdown with phenotypic readout Journal of medical genetics Medium 28626029
2016 A TRAPPC6B c.485G>A splice-site variant promotes exon 3-skipping and disrupts normal TRAPPC6B transcript processing, as demonstrated by minigene transfection assay and analysis of patient transcripts. Minigene transfection splicing assay and RT-PCR of patient transcripts Parkinsonism & related disorders Medium 27569842
2020 RNAi-mediated silencing of TRAPPC6B in ACHN human renal epithelial cells confers protection against Shiga toxin 2a cytotoxicity, linking TRAPPC6B to intracellular Shiga toxin trafficking. RNAi knockdown with cell viability readout after Shiga toxin challenge Scientific reports Low 32188865
2024 Human TRAPPC6B can functionally replace its yeast counterpart (Trs33) in Saccharomyces cerevisiae, demonstrating functional conservation of the protein across species. CRISPR/Cas9-mediated humanized yeast complementation assay Cells Medium 39273027

Source papers

Stage 0 corpus · 13 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2017 Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families. Molecular psychiatry 146 28397838
2017 A homozygous founder mutation in TRAPPC6B associates with a neurodevelopmental disorder characterised by microcephaly, epilepsy and autistic features. Journal of medical genetics 40 28626029
2021 Circular RNA TRAPPC6B inhibits intracellular Mycobacterium tuberculosis growth while inducing autophagy in macrophages by targeting microRNA-874-3p. Clinical & translational immunology 35 33708385
2016 Trs33-Containing TRAPP IV: A Novel Autophagy-Specific Ypt1 GEF. Genetics 26 27672095
2020 RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells. Scientific reports 10 32188865
2016 A TRAPPC6B splicing variant associates to restless legs syndrome. Parkinsonism & related disorders 8 27569842
2024 TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions. Brain : a journal of neurology 5 37713627
2024 A Humanized Yeast Model for Studying TRAPP Complex Mutations; Proof-of-Concept Using Variants from an Individual with a TRAPPC1-Associated Neurodevelopmental Syndrome. Cells 4 39273027
2019 Further Delineation of the TRAPPC6B Disorder: Report on a New Family and Review. Journal of pediatric genetics 3 31687267
2022 Description of novel variants in consanguineous Pakistani families affected with intellectual disability. Genes & genomics 1 35150401
2025 [Analysis of clinical phenotype and gene variation of a child with neurodevelopmental disorder caused by homozygous variation of TRAPPC6B gene]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 0 40350395
2025 Macrophage targeted cellular microparticles synergize anti-tuberculosis therapy combining CircRNA-mediated host immune defense and antibiotic killing. Materials today. Bio 0 41356416
2025 Transcriptome-wide association study of prostate cancer in the Chinese population. Asian journal of urology 0 42238340

Missed literature

Know a paper Affinage missed for TRAPPC6B? Flag it for the maintainers and the community.

No submissions yet.